Cogent Biosciences Inc. (COGT)
Cogent Biosciences Statistics
Share Statistics
Cogent Biosciences has 113.85M shares outstanding. The number of shares has increased by 19.07% in one year.
| Shares Outstanding | 113.85M |
| Shares Change (YoY) | 19.07% |
| Shares Change (QoQ) | 3.07% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 95.39M |
| Failed to Deliver (FTD) Shares | 1.39K |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 9.35M, so 8.47% of the outstanding shares have been sold short.
| Short Interest | 9.35M |
| Short % of Shares Out | 8.47% |
| Short % of Float | 10.52% |
| Short Ratio (days to cover) | 6.41 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is -3.92. Cogent Biosciences's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | -3.92 |
| PS Ratio | 0 |
| Forward PS | 1.2 |
| PB Ratio | 2.23 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cogent Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.32, with a Debt / Equity ratio of undefined.
| Current Ratio | 5.32 |
| Quick Ratio | 5.32 |
| Debt / Equity | undefined |
| Total Debt / Capitalization | 6.38 |
| Cash Flow / Debt | -11.9 |
| Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is -1% and return on capital (ROIC) is -100.8%.
| Return on Equity (ROE) | -1% |
| Return on Assets (ROA) | -0.78% |
| Return on Capital (ROIC) | -100.8% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,248,092.68 |
| Employee Count | 205 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -13.04% in the last 52 weeks. The beta is 0.08, so Cogent Biosciences's price volatility has been higher than the market average.
| Beta | 0.08 |
| 52-Week Price Change | -13.04% |
| 50-Day Moving Average | 7.83 |
| 200-Day Moving Average | 9.17 |
| Relative Strength Index (RSI) | 33.17 |
| Average Volume (20 Days) | 1.36M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -275.94M |
| Net Income | -255.86M |
| EBITDA | -275.94M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.49 |
Balance Sheet
The company has 98.17M in cash and 17.47M in debt, giving a net cash position of 80.7M.
| Cash & Cash Equivalents | 98.17M |
| Total Debt | 17.47M |
| Net Cash | 80.7M |
| Retained Earnings | -859.48M |
| Total Assets | 327.9M |
| Working Capital | 240.76M |
Cash Flow
In the last 12 months, operating cash flow was -207.79M and capital expenditures 0, giving a free cash flow of -207.79M.
| Operating Cash Flow | -207.79M |
| Capital Expenditures | 0 |
| Free Cash Flow | -207.79M |
| FCF Per Share | -2.83 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -58.17% |
| FCF Yield | -30.39% |
Analyst Forecast
The average price target for COGT is $14.5, which is 141.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.5 |
| Price Target Difference | 141.7% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Nov 9, 2020. It was a backward split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | 0.73 |
| Piotroski F-Score | 1 |